← Human Trials & Peer-Reviewed Studies

Atrial Natriuretic Peptide in the High Normal Range Is Associated With Lower Prevalence of Insulin Resistance

Plain-language guide to PMID 26815880 (2016): randomized controlled trial study of ANP (Atrial Natriuretic Peptide) in 2243 subjects, insulin resistance, prediabetes & type 2 diabetes.

Key Facts

PMID
26815880
Journal
The Journal of clinical endocrinology and metabolism
Year
2016
Study type
Randomized Controlled Trial
Authors
Jujić A et al. (9 authors)
DOI
10.1210/jc.2015-3518

What This Study Did, in Plain Language

What Was Tested

This randomized controlled trial paper looks at ANP (Atrial Natriuretic Peptide) in the context of insulin resistance, prediabetes & type 2 diabetes.

Who Took Part

The abstract describes 2243 subjects taking part.

The age groups tagged for this paper are middle-aged adults, both men and women.

In 2243 subjects, MR-proANP was measured at baseline.

How the Study Was Run

The researchers set it up as a randomized study.

The subjects were allocated by chance, so the ANP (Atrial Natriuretic Peptide) group and the comparison group should start out alike.

What Was Measured

The subject headings attached to it are Atrial Natriuretic Factor, Biomarkers, Heart Failure, Insulin Resistance and Prevalence.

What This Means in Plain Language

The paper is a randomized study of ANP (Atrial Natriuretic Peptide) in 2243 subjects in people with insulin resistance, prediabetes & type 2 diabetes.

With several hundred people or more, it is a fairly large study for this kind of research.

The publication is from 2016 (The Journal of clinical endocrinology and metabolism), a journal based in United States.

More context: the ANP (Atrial Natriuretic Peptide) compound page, Insulin resistance, prediabetes & type 2 diabetes research.

Our Notes on the Compound

ANP (Atrial Natriuretic Peptide): A 28-amino-acid heart hormone that relaxes blood vessels and increases salt excretion; carperitide is a recombinant form.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.